Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

BACKGROUND: In the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study, Cladribine Tablets significantly improved clinical and magnetic resonance imaging (MRI) outcomes (vs placebo) in patients with relapsing-remitting multiple sclerosis. OBJECTIVE: Describe two clinically relevant...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mult Scler
Auteurs principaux: Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil W, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Hicking, Christine, Vermersch, Patrick
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2018
Sujets:
Original Research Papers
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6460686/
https://ncbi.nlm.nih.gov/pubmed/29716436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458518771875
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires